An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
SR Prickett - Clinical & Experimental Allergy, 2012 - Wiley Online Library
Background Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …
[HTML][HTML] An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
P Starkl, F Felix, D Krishnamurthy… - … allergy: journal of the …, 2012 - ncbi.nlm.nih.gov
Background Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …
[引用][C] An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
P STARKL, F FELIX, RE O'HEHIR… - Clinical and …, 2012 - pascal-francis.inist.fr
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic
potential CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
potential CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.
P Starkl, F Felix, D Krishnamurthy, C Stremnitzer… - 2012 - cabidigitallibrary.org
Background: Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
P Starkl, F Felix, D Krishnamurthy… - … allergy: journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
P Starkl, F Felix, D Krishnamurthy, C Stremnitzer… - Clinical & Experimental …, 2012 - infona.pl
Background Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential
P Starkl, F Felix, D Krishnamurthy… - Clinical and …, 2012 - research.monash.edu
Peanut allergy causes severe type 1 hypersensitivity reactions and conventional
immunotherapy against peanut allergy is associated with a high risk of anaphylaxis …
immunotherapy against peanut allergy is associated with a high risk of anaphylaxis …
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.
P Starkl, F Felix, D Krishnamurthy… - … Allergy: Journal of …, 2012 - europepmc.org
Background Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.
P Starkl, F Felix, D Krishnamurthy… - Clinical & …, 2012 - search.ebscohost.com
Background Peanut allergy causes severe type 1 hypersensitivity reactions and
conventional immunotherapy against peanut allergy is associated with a high risk of …
conventional immunotherapy against peanut allergy is associated with a high risk of …